Bile duct cancer, also known as cholangiocarcinoma, is a rare type of cancer that forms in the bile duct. The bile duct is the tube that carries bile from the liver to the small intestine. Bile duct cancer occurs in the small tubes (small bile ducts) inside the liver or the large tube (large bile duct) outside the liver. The global bile duct cancer market involves drugs, therapies and surgical procedures associated with treatment of this type of cancer. The increasing research and development activities for development of novel drugs and combination therapies provides growth opportunities in this market.

The global bile duct cancer Market is estimated to be valued at US$ 235.9 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

One of the major drivers fueling the growth of the bile duct cancer market is the increasing prevalence of this type of cancer worldwide. According to the American Cancer Society, about 8,000 new cases of bile duct cancer occur each year in the United States, accounting for about 1-2% of all gastrointestinal cancers. The risk of developing bile duct cancer increases with age and is most commonly diagnosed in the 70-79 age group. Moreover, the growing research and development investments by key market players for development of novel combination therapies is also supplementing the market growth. Government support and funding for cancer research further propels the market growth over the forecast period.

SWOT Analysis

Strength: The bile duct cancer market is witnessing high growth on account of increasing prevalence of bile duct cancer worldwide. Furthermore, rising research and development activities for more effective treatment options also acts as a strength for the market. Availability of late stage pipeline drugs will further provide new treatment alternatives to patients.

Weakness: Low diagnosis rate for bile duct cancer acts as a weakness for the market. Due to non-specific symptoms in early stages, most cases are diagnosed at an advanced stage. High cost of treatment also limits full access to quality care.

Opportunity: Growing healthcare expenditure in emerging nations provides lucrative growth opportunities. Furthermore, initiatives to spread awareness regarding symptoms can help improve early detection rate.

Threats: Delay in drug approvals is a major threat. Strong regulatory framework for drug approval acts as a challenge especially for novel therapies.

Key Takeaways

The Global Bile Duct Cancer Market Size is expected to witness high growth. Rapidly increasing prevalence of bile duct cancer worldwide will drive the market growth during the forecast period. According to latest report by Straits Research, the global bile duct cancer market was valued at US$ 235.9 Mn in 2023 and expanding at a stellar CAGR of 12% over the forecast period.

Regional analysis

North America currently dominates the global bile duct cancer market and is expected to maintain its lead during the forecast period as well. High healthcare spending, advanced healthcare infrastructure, presence of major players and increasing investment in development of novel therapies contributes to large share of the region. For instance, US spends around 16-18% of its GDP on health annually. However, Asia Pacific is expected grow at the fastest pace due to large patient pool, improving access to healthcare facilities and growing healthcare spending in the region.

Key players

Key players operating in the bile duct cancer market are Incyte Corporation, Eisai Co., Ltd., QED Therapeutics, Inc., Agios Pharmaceuticals, Inc., RenovoRx, Ability Pharmaceuticals, Imbrium Therapeutics L.P. and Delcath Systems, Inc. Major players are focused on conducting clinical trials to expand indications of existing drugs and develop novel therapies. They are also adopting collaboration and acquisition strategies to strengthen their product portfolio and dominance in the market.

Get More Insights Here

https://www.trendingwebwire.com/bile-duct-cancer-market-size-share-growth-outlook-2023/